Abstract LB-323: A novel function of ETS transcription factors in alternative splicing is altered in oncogenic FET-ETS fusions
Authors: Olivier Saulnier, Katia Guerdi, Marie-Ming Aynaud, Alina Chakraborty, Josephine Pineau, Christina O Grady, Martin Dutertre, Franck Dequiedt, Olivier Delattre
Journal: Cancer Research (2018)

Abstract Ewing sarcomas are characterized by fusions proteins between FET (FUS, EWS and TAF15) family genes encoding RNA binding proteins and ETS (ERG, FLI1 and FEV) family genes encoding transcription factors. FET-ETS fusions regulate both transcription and alternative splicing programs in Ewing sarcoma cells. To date, the function of FET-ETS fusions in splicing is mostly attributed to the FET N-terminal region which is preserved in the fusions. We recently demonstrated that wild type ERG associates with poly-adenylated mRNA and control mRNAs stability in the cytoplasm (Rambout et al., 2016). This therefore indicates that ERG proteins might not be considered only as transcription factors, but can also regulate post-transcriptional processes. On this ground, we hypothesize that ERG proteins might control other post-transcriptional processes, including splicing. In this study, we show that the ERG transcription factor interacts with several spliceosome components and is associated with nascent RNA. Tethered ERG proteins controlled alternative splicing of a minigene reporter in an orientation-specific manner. Deep RNA-seq identified hundreds of alternatively spliced exons regulated by ERG depletion, with an enrichment in RNA motifs bound by RBFOX2 splicing factor. RBFOX2 similarly regulated alternative splicing of common targets and interacted together via the C-terminal domain of ERG which is present in FET-ERG fusions. In Ewing sarcoma cells, RNA-seq identified hundreds of alternatively spliced exons regulated by EWS-FLI1 depletion, with an enrichment in RNA motifs bound by RBFOX2. The oncogenic EWS-FLI1 protein binds RBFOX2 protein but has an antagonist effect on RBFOX2 function. Cross-linking immunoprecipitation (CLIP) experiments show that the EWS-FLI1 fusion inhibits RBFOX2 function by repressing its binding to target pre-mRNAs. We hypothesize that the low complexity prion-like domain of EWS included in the fusion protein may be responsible for sequestration of RBFOX2 outside of the splicing machinery. Importantly, we also show that some of the splicing events induced by the fusion protein may play a critical role in FET-ETS induced cell phenotype. Specific splicing switch partially recapitulate the phenotypic changes that participate in FET-ETS induced cell transformation. These data reveal a new role for ERG family proteins in alternative splicing that is altered in FET-ETS oncogenic proteins, thereby contributing to alternative splicing mis-regulation and cell phenotype in Ewing sarcoma. Citation Format: Olivier Saulnier, Katia Guerdi, Marie-Ming Aynaud, Alina Chakraborty, Josephine Pineau, Christina O Grady, Martin Dutertre, Franck Dequiedt, Olivier Delattre. A novel function of ETS transcription factors in alternative splicing is altered in oncogenic FET-ETS fusions [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr LB-323.